394 related articles for article (PubMed ID: 30108195)
21. Interleukin-18 primes human basophilic KU812 cells for higher leukotriene synthesis.
Zaitsu M; Yamasaki F; Ishii E; Midoro-Horiuti T; Goldblum RM; Hamasaki Y
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):61-6. PubMed ID: 16280246
[TBL] [Abstract][Full Text] [Related]
22. The 5-lipoxygenase pathway regulates vasculogenesis in differentiating mouse embryonic stem cells.
Finkensieper A; Kieser S; Bekhite MM; Richter M; Mueller JP; Graebner R; Figulla HR; Sauer H; Wartenberg M
Cardiovasc Res; 2010 Apr; 86(1):37-44. PubMed ID: 19965960
[TBL] [Abstract][Full Text] [Related]
23. Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis.
Gür ZT; Çalışkan B; Banoglu E
Eur J Med Chem; 2018 Jun; 153():34-48. PubMed ID: 28784429
[TBL] [Abstract][Full Text] [Related]
24. Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases.
Jupp J; Hillier K; Elliott DH; Fine DR; Bateman AC; Johnson PA; Cazaly AM; Penrose JF; Sampson AP
Inflamm Bowel Dis; 2007 May; 13(5):537-46. PubMed ID: 17230539
[TBL] [Abstract][Full Text] [Related]
25. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
Steinke JW; Culp JA
Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
[TBL] [Abstract][Full Text] [Related]
26. Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy.
Sveinbjörnsson B; Rasmuson A; Baryawno N; Wan M; Pettersen I; Ponthan F; Orrego A; Haeggström JZ; Johnsen JI; Kogner P
FASEB J; 2008 Oct; 22(10):3525-36. PubMed ID: 18591367
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of leukotriene biosynthesis.
Ford-Hutchinson AW
Ann N Y Acad Sci; 1991; 629():133-42. PubMed ID: 1952545
[No Abstract] [Full Text] [Related]
28. Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP.
Häfner AK; Gerstmeier J; Hörnig M; George S; Ball AK; Schröder M; Garscha U; Werz O; Steinhilber D
Biochim Biophys Acta; 2015 Nov; 1851(11):1465-72. PubMed ID: 26327594
[TBL] [Abstract][Full Text] [Related]
29. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis.
Figueroa DJ; Borish L; Baramki D; Philip G; Austin CP; Evans JF
Clin Exp Allergy; 2003 Oct; 33(10):1380-8. PubMed ID: 14519144
[TBL] [Abstract][Full Text] [Related]
30. Roles of coactosin-like protein (CLP) and 5-lipoxygenase-activating protein (FLAP) in cellular leukotriene biosynthesis.
Basavarajappa D; Wan M; Lukic A; Steinhilber D; Samuelsson B; Rådmark O
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11371-6. PubMed ID: 25034252
[TBL] [Abstract][Full Text] [Related]
31. Beyond leukotriene formation-The noncanonical functions of 5-lipoxygenase.
Häfner AK; Kahnt AS; Steinhilber D
Prostaglandins Other Lipid Mediat; 2019 Jun; 142():24-32. PubMed ID: 30930090
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitors of 5-lipoxygenase].
Gápovský M; Remko M
Ceska Slov Farm; 2002 Mar; 51(2):55-62. PubMed ID: 11928277
[TBL] [Abstract][Full Text] [Related]
33. The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP).
Pergola C; Gerstmeier J; Mönch B; Çalışkan B; Luderer S; Weinigel C; Barz D; Maczewsky J; Pace S; Rossi A; Sautebin L; Banoglu E; Werz O
Br J Pharmacol; 2014 Jun; 171(12):3051-64. PubMed ID: 24641614
[TBL] [Abstract][Full Text] [Related]
34. 5-Lipoxygenase.
Ford-Hutchinson AW; Gresser M; Young RN
Annu Rev Biochem; 1994; 63():383-417. PubMed ID: 7979243
[No Abstract] [Full Text] [Related]
35. FLAP: a novel drug target for inhibiting the synthesis of leukotrienes.
Ford-Hutchinson AW
Trends Pharmacol Sci; 1991 Feb; 12(2):68-70. PubMed ID: 2024291
[TBL] [Abstract][Full Text] [Related]
36. [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
[TBL] [Abstract][Full Text] [Related]
37. Leukotrienes in Tumor-Associated Inflammation.
Tian W; Jiang X; Kim D; Guan T; Nicolls MR; Rockson SG
Front Pharmacol; 2020; 11():1289. PubMed ID: 32973519
[TBL] [Abstract][Full Text] [Related]
38. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
Parker AR; Ayars AG; Altman MC; Henderson WR
Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
[TBL] [Abstract][Full Text] [Related]
39. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands.
Alestas T; Ganceviciene R; Fimmel S; Müller-Decker K; Zouboulis CC
J Mol Med (Berl); 2006 Jan; 84(1):75-87. PubMed ID: 16388388
[TBL] [Abstract][Full Text] [Related]
40. In vivo modulation of LPS induced leukotrienes generation and oxidative stress by sesame lignans.
Yashaswini PS; Sadashivaiah B; Ramaprasad TR; Singh SA
J Nutr Biochem; 2017 Mar; 41():151-157. PubMed ID: 28095362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
